ICU Medical, Inc.

ICUI Healthcare Medical Instruments & Supplies

ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 46.9%, free cash flow grew 656.0% and total debt fell 7.96%, each against the same quarter a year earlier.

162.99 4.24 −2.54%
Market cap
$4.2B
P/E
136×
Fwd P/E
49.5×
Dividend yield
—
F-score
6/9
Altman Z
2.12
Beneish M
−2.65
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
6 6 6 7

+8 more TTM periods

ROE
1.41% 2.26% 0.04% (0.35%)
ROA
0.74% 1.13% 0.02% (0.18%)
ROIC
1.46% 0.88% 0.86% 1.49%
Return on Tangible Assets
2.60% 4.06% 0.06% (0.63%)
Average Days of Receivables
31.02 34.03 29.53 30.13
Free Cash Flow per Share
6.12 3.31 3.69 2.52
Free Cash Flow
152.88 82.08 90.89 62.33
Other line items

Show all line items

Columns are period end dates